Marrone Bio Innovations Inc (MBII) 2.99 $MBII
Marrone Bio Innovations wins REGALIA MAXX Biofungicide's registration in Brazil to control bacterial and fungal diseases across agricultural crops
M2 - Thu Dec 18, 5:14AM CST
Plant health company Marrone Bio Innovations (NasdaqGM:MBI) reported on Wednesday that it has received Brazil's Ministry of Agriculture's (MAPA) registration for REGALIA MAXX Biofungicide to control a wide variety of bacterial and fungal diseases across an array of agricultural crops.
MBI: 9.66 (+0.20), MBII: 2.99 (-0.08)
Marrone Bio Innovations' REGALIA(R) MAXX Biofungicide Receives Registration in Brazil
GlobeNewswire - Wed Dec 17, 8:36AM CST
Marrone Bio Innovations, Inc. (MBI), (Nasdaq:MBII), a leading provider of bio-based pest management and plant health products for the agriculture, turf and ornamental and water treatment markets, today announced that its REGALIA MAXX Biofungicide has received a product registration from Brazil's Ministry of Agriculture (MAPA). Brazil now joins Peru, El Salvador, Guatemala, Honduras, Panama, Columbia, the Dominican Republic and Mexico as Latin American countries having approved the use of REGALIA MAXX to control a wide variety of bacterial and fungal diseases across an array of agricultural crops.
MBII: 2.99 (-0.08)
Global Biologicals Market - Micro Market Monitor 2014
M2 - Fri Dec 12, 4:07AM CST
Research and Markets (http://www.researchandmarkets.com/research/x7snhs/micro_market) has announced the addition of the "Micro Market Monitor: Global Biologicals Market" report to their offering. The global agricultural biologicals market is estimated to grow at a CAGR of 14.6% from 2014 to 2019 Although the mature markets (such as the U.S., Spain, and Italy) hold larger shares in the agricultural biologicals market, the European region is expected to grow at the fastest CAGR of 15.2% during the forecast period, 2014 to 2019. The growth of the agricultural biologicals market is driven by various factors, such as the increasing demand for organic products, rising world population, reduced chemical hazards, and easier residue management. Moreover, emerging economies such as India, China, and Japan are creating huge growth opportunities for the agricultural biologicals market in the Asia-Pacific region. However, factors such as barriers in adoption of biologicals and lack of awareness are restraining the growth of this market. In this report, the global agricultural biologicals market has been broadly classified into three main types, namely biopesticides, biostimulants, and biofertilizers. The biopesticides market segment is estimated to grow at the fastest CAGR from 2014 to 2019, as compared to the other two types. Factors such as phasing out of the prevalence of highly toxic pesticides, improved awareness among farmers regarding the advantages of use of biopesticides, and the increased demand for organic farming are driving the growth of this market. The global agricultural biologicals market is a competitive market with a number of market players with niche technologies. As of 2014, the global agricultural biologicals market is dominated by BASF SE (Germany), Bayer CropScience (Germany), Marrone Bio Innovations, Inc. (U.S.), and Novozymes A/S (Denmark), among others. New product launches, partnerships, agreements, collaborations, and joint ventures are the major strategies adopted by most market players to achieve growth in the agricultural biologicals market. Key Topics Covered: 1 Introduction 2 Research Methodology 3 Executive Summary 4 Market Overview 5 Global Agricultural Biologicals Market, By Application 6 Global Agricultural Biologicals Market, By Type 7 Global Agricultural Biologicals Market, By Geography 8 Competitive Landscape 9 Company Profiles - Agrinos As - Basf Se - Bayer Cropscience Ag - Camson Biotechnologies Limited - Certis Usa Llc - Isagro Spa - Koppert B.V. - Marrone Bio Innovation Inc. - Novozymes A/S - T. Stanes & Company Limited - Valent Bio-Science For more information visit http://www.researchandmarkets.com/research/x7...cro_market
MBII: 2.99 (-0.08)
Marrone Bio Innovations to inaugurate new bigger corporate headquarters on 8 December
M2 - Wed Dec 03, 7:05AM CST
Plant health company Marrone Bio Innovations (NasdaqGM:MBII) announced on Tuesday the transfer of its corporate headquarters to 1540 Drew Avenue, Davis, CA 95618, with effect from 8 December 2014.
MBII: 2.99 (-0.08)
Marrone Bio Innovations Announces New Corporate Headquarters Location
GlobeNewswire - Tue Dec 02, 7:39AM CST
Marrone Bio Innovations, Inc. (MBI), (Nasdaq:MBII), a leading provider of bio-based pest management and plant health products for the agriculture, turf and ornamental and water treatment markets, today announced that it has relocated its corporate headquarters to 1540 Drew Avenue, Davis, CA 95618, effective December 8, 2014.
MBII: 2.99 (-0.08)
Marrone Bio Innovations Receives NASDAQ Notice Regarding Late Form 10-Q Filing
Business Wire - Fri Nov 21, 3:01PM CST
Marrone Bio Innovations, Inc. (MBI) (NASDAQ:MBII) today announced that, as anticipated, it has received a letter from the Listing Qualifications Department of The NASDAQ Stock Market LLC ("NASDAQ"
notifying MBI of its noncompliance with NASDAQ Listing Rule 5250(c)(1) as a result of the company's filing of a Notification of Late Filing on Form 12b-25 on November 14, 2014. In the Form 12b-25, the company indicated that the filing of its Quarterly Report on Form 10-Q for the quarter ended September 30, 2014 (the "Form 10-Q" will be delayed until after the completion of the previously-disclosed internal investigation by the Company's Audit Committee regarding certain accounting matters.
MBII: 2.99 (-0.08)
Marrone Bio Innovations' Marrone Michigan Manufacturing Facility Recognized by the Michigan Agri-Business Association for Contributions to Sustainable Agriculture
GlobeNewswire - Thu Nov 13, 7:30AM CST
Marrone Bio Innovations, Inc. (MBI), (Nasdaq:MBII), a leading provider of bio-based pest management and plant health products for the agriculture, turf and ornamental and water treatment markets, is pleased to announce that its Marrone Michigan Manufacturing (M3) facility in Bangor, Michigan has received a 2014 "Green Agribusiness Award" from the Michigan Agri-Business Association (MABA).
MBII: 2.99 (-0.08)
Schubert Law Firm Launches Investigation into Marrone Bio Innovations' Top Executives Regarding Possible Breaches of Their Fiduciary Duties
PR Newswire - Wed Nov 12, 10:00AM CST
Shareholder and consumer rights law firm Schubert Jonckheer & Kolbe LLP today launched an investigation into whether certain officers and directors of Marrone Bio Innovations, Inc. (NASDAQ: MBII) breached their fiduciary duties to Marrone Bio and its shareholders.
MBII: 2.99 (-0.08)
Air Products to Launch Gas Blending System at FABTECH - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Nov 05, 5:35PM CST
Air Products (APD) will launch its Maxx Pak portable shielding gas blending system at FABTECH 2014.
MBII: 2.99 (-0.08), CE: 60.31 (+0.12), HUN: 23.39 (-0.13), APD: 148.58 (unch)
SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action against Marrone Bio Innovations, Inc. and Certain Officers - MBII
PR Newswire - Fri Oct 31, 2:13PM CDT
Pomerantz LLP has filed a class action lawsuit against Marrone Bio Innovations, Inc. ("Marrone" or the "Company" (NASDAQ: MBII) and certain of its officers. The class action, filed in United States District Court, Eastern District of California, and docketed under 14-cv-02055, is on behalf of a class consisting of all persons or entities who purchased Marrone securities between March 6, 2014 and September 2, 2014, inclusive (the "Class Period" . This class action seeks to recover damages against Defendants for alleged violations of the federal securities laws under the Securities Exchange Act of 1934 (the "Exchange Act" .
MBII: 2.99 (-0.08)
Marrone Bio Innovations CEO Pam Marrone Receives Agrow Award for Best Manager With a Strategic Vision
GlobeNewswire - Thu Oct 30, 9:07AM CDT
Marrone Bio Innovations, Inc. (MBI) (Nasdaq:MBII), a leading global provider of bio-based pest management and plant health products, announced today that its Founder and Chief Executive Officer Pam Marrone has received a 2014 Agrow Award for "Best Manager with Strategic Vision." Marrone was honored at the Agrow Awards' 2014 ceremony and dinner last night in Amsterdam.
MBII: 2.99 (-0.08)
UPCOMING DEADLINE ALERT: Brower Piven Encourages Investors Who Have Losses in Excess of $100,000 From Investment in Marrone Bio Innovations, Inc. to Contact Brower Piven Before the November 4, 2014 Lead Plaintiff Deadline -- MBII
GlobeNewswire - Wed Oct 29, 12:05PM CDT
The securities litigation law firm of Brower Piven, A Professional Corporation, announces that a class action lawsuit has been commenced in the United States District Court for the Eastern District of California on behalf of purchasers of Marrone Bio Innovations, Inc. ("Marrone" or the "Company" (Nasdaq:MBII) securities during the period between March 6, 2014 and September 2, 2014, inclusive (the "Class Period" . Investors who wish to become proactively involved in the litigation have until November 4, 2014 to seek appointment as lead plaintiff.
MBII: 2.99 (-0.08)
Marrone Bio Innovations names Brian Ahrens as VP of Sales
M2 - Tue Oct 28, 5:53AM CDT
Plant health company Marrone Bio Innovations (NasdaqGM:MBII) revealed on Monday that it has appointed Brian Ahrens as its vice president of Sales.
MBII: 2.99 (-0.08)
SHAREHOLDER ALERT: LEVI & KORSINSKY, LLP Notifies Investors of Class Action Against Marrone Bio Innovations, Inc. and Its Board of Directors and a Lead Plaintiff Deadline of November 4, 2014 -- MBII
GlobeNewswire - Mon Oct 27, 3:10PM CDT
Levi & Korsinsky announces that a class action lawsuit has been commenced in the United States District Court for the Eastern District of California on behalf of investors who purchased Marrone Bio Innovations, Inc. ("Marrone Bio" or the "Company" (Nasdaq:MBII) securities between March 6, 2014 and September 2, 2014.
MBII: 2.99 (-0.08)
Brian Ahrens Joins Marrone Bio Innovations as Vice President of Sales
GlobeNewswire - Mon Oct 27, 7:41AM CDT
Marrone Bio Innovations, Inc. (MBI) (Nasdaq:MBII), a leading provider of bio-based pest management and plant health products for the agriculture, turf and ornamental and water treatment markets, today announced that Brian Ahrens has joined the company as its Vice President of Sales. In this role, Ahrens will be responsible for driving U.S. and international sales of MBI's portfolio of products to growers through distributors and retailers of agriculture products.
MBII: 2.99 (-0.08)
MARRONE BIO SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Reminds Investors With Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Marrone Bio Innovations, Inc. -- MBII
GlobeNewswire - Sat Oct 25, 4:38PM CDT
Kahn Swick & Foti, LLC ("KSF" and KSF partner, the former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until November 4, 2014 to file lead plaintiff applications in a securities class action lawsuit against Marrone Bio Innovations, Inc. (Nasdaq:MBII), if they purchased the Company's securities between March 6, 2014 and September 2, 2014, inclusive (the "Class Period" . This action is pending in the United States District Court for the Eastern District of California.
MBII: 2.99 (-0.08)
SHAREHOLDER ALERT: The Wagner Firm Announces Lead Plaintiff Deadline in the Class Action Lawsuit against Marrone Bio Innovations, Inc.
Business Wire - Fri Oct 24, 10:30AM CDT
The Wagner Firm reminds investors that purchasers of the securities of Marrone Bio Innovations, Inc. ("Marrone" or the "Company" (NASDAQ:MBII) between the Company's August 2, 2013 Initial Public Offering and September 2, 2014, inclusive (the "Class Period" , have until November 4, 2014, to file a motion to be appointed as lead plaintiff in the shareholder lawsuit filed in the United States District Court for the Eastern District of California.
MBII: 2.99 (-0.08)
Bon Appétech Launches the "Good Food Innovation" Movement, with a Global Food Technology Conference to Kick Off in San Francisco April 2015
PRWeb - Fri Oct 24, 8:07AM CDT
Bon Appétech is announcing the launch of the "Good Food Innovation" movement, with its premiere global food technology conference to be held in San Francisco in April 2015. At the core of the "Good Food Innovation" movement is an emphasis on empowering the food community to ensure that innovation is used to improve the food system and increase access to healthy, sustainable food. The conference will bring together food innovators, artisan food and beverage producers, chefs, entrepreneurs, food startups, global brands and investors to celebrate and explore novel ideas, showcase amazing food products, and discuss how innovation can help improve the food system.
MBII: 2.99 (-0.08)
Hagens Berman Reminds All Investors in Marrone Bio Innovations, Inc. (MBII) of November 4, 2014, Lead Plaintiff Deadline and Expanded Class Period
Marketwired - Wed Oct 22, 7:32AM CDT
Hagens Berman Sobol Shapiro LLP, a top-tier investor-rights law firm, advises investors of the upcoming Nov. 4, 2014 lead plaintiff deadline in the securities fraud class action against Marrone Bio Innovations, Inc. (NASDAQ: MBII) ("Marrone" or "the Company" , filed in the U.S. District Court for the Eastern District of California, and the expanded class period which now includes all investors as far back as the initial public offering (IPO).
MBII: 2.99 (-0.08)
Market Maker Surveillance Report. FST, UIS, HSTM, MEIL, VPCO, MBII, Winning Stocks With Lowest Price Friction For Tuesday, October 21st 2014
M2 - Wed Oct 22, 3:35AM CDT
BUYINS.NET / www.buyins.net, announced today its proprietary Market Maker Friction Factor Report for Tuesday. Since October 2008 market makers are now required to be on the bid as much as they are on the offer and for like amounts of stock. This Fair Market Making Requirement is designed to prevent market makers from manipulating stock prices. On Tuesday there were 4741 companies with "abnormal" market making, 3722 companies with positive Friction Factors and 1380 companies with negative Friction Factors. Here is a list of the top companies with the largest percentage gain per share Tuesday and low price friction (bullish). This means that there was more buying than selling in the stocks and their stock prices rose faster with less Friction. Forest Oil Corp (NYSE:FST), Unisys Corp (NYSE:UIS), HealthStream Inc (NASDAQ:HSTM), MEI DIVERSIFIED LIQU (:MEIL), Vapor Corp (OTC:VPCO), (NASDAQ:MBII). To access Friction Factor, Naked Short Data and SqueezeTrigger Prices on all stocks please visit http://www.buyins.net .
MBII: 2.99 (-0.08), FST: 0.34 (-0.02), HSTM: 29.18 (+0.21), UIS: 29.77 (-0.43), VPCO: 1.30 (-0.01)
Marrone Bio Innovations wins REGALIA MAXX Biofungicide's registration in Brazil to control bacterial and fungal diseases across agricultural crops
M2 - Thu Dec 18, 5:14AM CST
Plant health company Marrone Bio Innovations (NasdaqGM:MBI) reported on Wednesday that it has received Brazil's Ministry of Agriculture's (MAPA) registration for REGALIA MAXX Biofungicide to control a wide variety of bacterial and fungal diseases across an array of agricultural crops.
MBI: 9.66 (+0.20), MBII: 2.99 (-0.08)
Marrone Bio Innovations' REGALIA(R) MAXX Biofungicide Receives Registration in Brazil
GlobeNewswire - Wed Dec 17, 8:36AM CST
Marrone Bio Innovations, Inc. (MBI), (Nasdaq:MBII), a leading provider of bio-based pest management and plant health products for the agriculture, turf and ornamental and water treatment markets, today announced that its REGALIA MAXX Biofungicide has received a product registration from Brazil's Ministry of Agriculture (MAPA). Brazil now joins Peru, El Salvador, Guatemala, Honduras, Panama, Columbia, the Dominican Republic and Mexico as Latin American countries having approved the use of REGALIA MAXX to control a wide variety of bacterial and fungal diseases across an array of agricultural crops.
MBII: 2.99 (-0.08)
Global Biologicals Market - Micro Market Monitor 2014
M2 - Fri Dec 12, 4:07AM CST
Research and Markets (http://www.researchandmarkets.com/research/x7snhs/micro_market) has announced the addition of the "Micro Market Monitor: Global Biologicals Market" report to their offering. The global agricultural biologicals market is estimated to grow at a CAGR of 14.6% from 2014 to 2019 Although the mature markets (such as the U.S., Spain, and Italy) hold larger shares in the agricultural biologicals market, the European region is expected to grow at the fastest CAGR of 15.2% during the forecast period, 2014 to 2019. The growth of the agricultural biologicals market is driven by various factors, such as the increasing demand for organic products, rising world population, reduced chemical hazards, and easier residue management. Moreover, emerging economies such as India, China, and Japan are creating huge growth opportunities for the agricultural biologicals market in the Asia-Pacific region. However, factors such as barriers in adoption of biologicals and lack of awareness are restraining the growth of this market. In this report, the global agricultural biologicals market has been broadly classified into three main types, namely biopesticides, biostimulants, and biofertilizers. The biopesticides market segment is estimated to grow at the fastest CAGR from 2014 to 2019, as compared to the other two types. Factors such as phasing out of the prevalence of highly toxic pesticides, improved awareness among farmers regarding the advantages of use of biopesticides, and the increased demand for organic farming are driving the growth of this market. The global agricultural biologicals market is a competitive market with a number of market players with niche technologies. As of 2014, the global agricultural biologicals market is dominated by BASF SE (Germany), Bayer CropScience (Germany), Marrone Bio Innovations, Inc. (U.S.), and Novozymes A/S (Denmark), among others. New product launches, partnerships, agreements, collaborations, and joint ventures are the major strategies adopted by most market players to achieve growth in the agricultural biologicals market. Key Topics Covered: 1 Introduction 2 Research Methodology 3 Executive Summary 4 Market Overview 5 Global Agricultural Biologicals Market, By Application 6 Global Agricultural Biologicals Market, By Type 7 Global Agricultural Biologicals Market, By Geography 8 Competitive Landscape 9 Company Profiles - Agrinos As - Basf Se - Bayer Cropscience Ag - Camson Biotechnologies Limited - Certis Usa Llc - Isagro Spa - Koppert B.V. - Marrone Bio Innovation Inc. - Novozymes A/S - T. Stanes & Company Limited - Valent Bio-Science For more information visit http://www.researchandmarkets.com/research/x7...cro_market
MBII: 2.99 (-0.08)
Marrone Bio Innovations to inaugurate new bigger corporate headquarters on 8 December
M2 - Wed Dec 03, 7:05AM CST
Plant health company Marrone Bio Innovations (NasdaqGM:MBII) announced on Tuesday the transfer of its corporate headquarters to 1540 Drew Avenue, Davis, CA 95618, with effect from 8 December 2014.
MBII: 2.99 (-0.08)
Marrone Bio Innovations Announces New Corporate Headquarters Location
GlobeNewswire - Tue Dec 02, 7:39AM CST
Marrone Bio Innovations, Inc. (MBI), (Nasdaq:MBII), a leading provider of bio-based pest management and plant health products for the agriculture, turf and ornamental and water treatment markets, today announced that it has relocated its corporate headquarters to 1540 Drew Avenue, Davis, CA 95618, effective December 8, 2014.
MBII: 2.99 (-0.08)
Marrone Bio Innovations Receives NASDAQ Notice Regarding Late Form 10-Q Filing
Business Wire - Fri Nov 21, 3:01PM CST
Marrone Bio Innovations, Inc. (MBI) (NASDAQ:MBII) today announced that, as anticipated, it has received a letter from the Listing Qualifications Department of The NASDAQ Stock Market LLC ("NASDAQ"
notifying MBI of its noncompliance with NASDAQ Listing Rule 5250(c)(1) as a result of the company's filing of a Notification of Late Filing on Form 12b-25 on November 14, 2014. In the Form 12b-25, the company indicated that the filing of its Quarterly Report on Form 10-Q for the quarter ended September 30, 2014 (the "Form 10-Q" will be delayed until after the completion of the previously-disclosed internal investigation by the Company's Audit Committee regarding certain accounting matters. MBII: 2.99 (-0.08)
Marrone Bio Innovations' Marrone Michigan Manufacturing Facility Recognized by the Michigan Agri-Business Association for Contributions to Sustainable Agriculture
GlobeNewswire - Thu Nov 13, 7:30AM CST
Marrone Bio Innovations, Inc. (MBI), (Nasdaq:MBII), a leading provider of bio-based pest management and plant health products for the agriculture, turf and ornamental and water treatment markets, is pleased to announce that its Marrone Michigan Manufacturing (M3) facility in Bangor, Michigan has received a 2014 "Green Agribusiness Award" from the Michigan Agri-Business Association (MABA).
MBII: 2.99 (-0.08)
Schubert Law Firm Launches Investigation into Marrone Bio Innovations' Top Executives Regarding Possible Breaches of Their Fiduciary Duties
PR Newswire - Wed Nov 12, 10:00AM CST
Shareholder and consumer rights law firm Schubert Jonckheer & Kolbe LLP today launched an investigation into whether certain officers and directors of Marrone Bio Innovations, Inc. (NASDAQ: MBII) breached their fiduciary duties to Marrone Bio and its shareholders.
MBII: 2.99 (-0.08)
Air Products to Launch Gas Blending System at FABTECH - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Nov 05, 5:35PM CST
Air Products (APD) will launch its Maxx Pak portable shielding gas blending system at FABTECH 2014.
MBII: 2.99 (-0.08), CE: 60.31 (+0.12), HUN: 23.39 (-0.13), APD: 148.58 (unch)
SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action against Marrone Bio Innovations, Inc. and Certain Officers - MBII
PR Newswire - Fri Oct 31, 2:13PM CDT
Pomerantz LLP has filed a class action lawsuit against Marrone Bio Innovations, Inc. ("Marrone" or the "Company"
(NASDAQ: MBII) and certain of its officers. The class action, filed in United States District Court, Eastern District of California, and docketed under 14-cv-02055, is on behalf of a class consisting of all persons or entities who purchased Marrone securities between March 6, 2014 and September 2, 2014, inclusive (the "Class Period" . This class action seeks to recover damages against Defendants for alleged violations of the federal securities laws under the Securities Exchange Act of 1934 (the "Exchange Act" . MBII: 2.99 (-0.08)
Marrone Bio Innovations CEO Pam Marrone Receives Agrow Award for Best Manager With a Strategic Vision
GlobeNewswire - Thu Oct 30, 9:07AM CDT
Marrone Bio Innovations, Inc. (MBI) (Nasdaq:MBII), a leading global provider of bio-based pest management and plant health products, announced today that its Founder and Chief Executive Officer Pam Marrone has received a 2014 Agrow Award for "Best Manager with Strategic Vision." Marrone was honored at the Agrow Awards' 2014 ceremony and dinner last night in Amsterdam.
MBII: 2.99 (-0.08)
UPCOMING DEADLINE ALERT: Brower Piven Encourages Investors Who Have Losses in Excess of $100,000 From Investment in Marrone Bio Innovations, Inc. to Contact Brower Piven Before the November 4, 2014 Lead Plaintiff Deadline -- MBII
GlobeNewswire - Wed Oct 29, 12:05PM CDT
The securities litigation law firm of Brower Piven, A Professional Corporation, announces that a class action lawsuit has been commenced in the United States District Court for the Eastern District of California on behalf of purchasers of Marrone Bio Innovations, Inc. ("Marrone" or the "Company"
(Nasdaq:MBII) securities during the period between March 6, 2014 and September 2, 2014, inclusive (the "Class Period" . Investors who wish to become proactively involved in the litigation have until November 4, 2014 to seek appointment as lead plaintiff. MBII: 2.99 (-0.08)
Marrone Bio Innovations names Brian Ahrens as VP of Sales
M2 - Tue Oct 28, 5:53AM CDT
Plant health company Marrone Bio Innovations (NasdaqGM:MBII) revealed on Monday that it has appointed Brian Ahrens as its vice president of Sales.
MBII: 2.99 (-0.08)
SHAREHOLDER ALERT: LEVI & KORSINSKY, LLP Notifies Investors of Class Action Against Marrone Bio Innovations, Inc. and Its Board of Directors and a Lead Plaintiff Deadline of November 4, 2014 -- MBII
GlobeNewswire - Mon Oct 27, 3:10PM CDT
Levi & Korsinsky announces that a class action lawsuit has been commenced in the United States District Court for the Eastern District of California on behalf of investors who purchased Marrone Bio Innovations, Inc. ("Marrone Bio" or the "Company"
(Nasdaq:MBII) securities between March 6, 2014 and September 2, 2014. MBII: 2.99 (-0.08)
Brian Ahrens Joins Marrone Bio Innovations as Vice President of Sales
GlobeNewswire - Mon Oct 27, 7:41AM CDT
Marrone Bio Innovations, Inc. (MBI) (Nasdaq:MBII), a leading provider of bio-based pest management and plant health products for the agriculture, turf and ornamental and water treatment markets, today announced that Brian Ahrens has joined the company as its Vice President of Sales. In this role, Ahrens will be responsible for driving U.S. and international sales of MBI's portfolio of products to growers through distributors and retailers of agriculture products.
MBII: 2.99 (-0.08)
MARRONE BIO SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Reminds Investors With Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Marrone Bio Innovations, Inc. -- MBII
GlobeNewswire - Sat Oct 25, 4:38PM CDT
Kahn Swick & Foti, LLC ("KSF"
and KSF partner, the former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until November 4, 2014 to file lead plaintiff applications in a securities class action lawsuit against Marrone Bio Innovations, Inc. (Nasdaq:MBII), if they purchased the Company's securities between March 6, 2014 and September 2, 2014, inclusive (the "Class Period" . This action is pending in the United States District Court for the Eastern District of California. MBII: 2.99 (-0.08)
SHAREHOLDER ALERT: The Wagner Firm Announces Lead Plaintiff Deadline in the Class Action Lawsuit against Marrone Bio Innovations, Inc.
Business Wire - Fri Oct 24, 10:30AM CDT
The Wagner Firm reminds investors that purchasers of the securities of Marrone Bio Innovations, Inc. ("Marrone" or the "Company"
(NASDAQ:MBII) between the Company's August 2, 2013 Initial Public Offering and September 2, 2014, inclusive (the "Class Period" , have until November 4, 2014, to file a motion to be appointed as lead plaintiff in the shareholder lawsuit filed in the United States District Court for the Eastern District of California. MBII: 2.99 (-0.08)
Bon Appétech Launches the "Good Food Innovation" Movement, with a Global Food Technology Conference to Kick Off in San Francisco April 2015
PRWeb - Fri Oct 24, 8:07AM CDT
Bon Appétech is announcing the launch of the "Good Food Innovation" movement, with its premiere global food technology conference to be held in San Francisco in April 2015. At the core of the "Good Food Innovation" movement is an emphasis on empowering the food community to ensure that innovation is used to improve the food system and increase access to healthy, sustainable food. The conference will bring together food innovators, artisan food and beverage producers, chefs, entrepreneurs, food startups, global brands and investors to celebrate and explore novel ideas, showcase amazing food products, and discuss how innovation can help improve the food system.
MBII: 2.99 (-0.08)
Hagens Berman Reminds All Investors in Marrone Bio Innovations, Inc. (MBII) of November 4, 2014, Lead Plaintiff Deadline and Expanded Class Period
Marketwired - Wed Oct 22, 7:32AM CDT
Hagens Berman Sobol Shapiro LLP, a top-tier investor-rights law firm, advises investors of the upcoming Nov. 4, 2014 lead plaintiff deadline in the securities fraud class action against Marrone Bio Innovations, Inc. (NASDAQ: MBII) ("Marrone" or "the Company"
, filed in the U.S. District Court for the Eastern District of California, and the expanded class period which now includes all investors as far back as the initial public offering (IPO). MBII: 2.99 (-0.08)
Market Maker Surveillance Report. FST, UIS, HSTM, MEIL, VPCO, MBII, Winning Stocks With Lowest Price Friction For Tuesday, October 21st 2014
M2 - Wed Oct 22, 3:35AM CDT
BUYINS.NET / www.buyins.net, announced today its proprietary Market Maker Friction Factor Report for Tuesday. Since October 2008 market makers are now required to be on the bid as much as they are on the offer and for like amounts of stock. This Fair Market Making Requirement is designed to prevent market makers from manipulating stock prices. On Tuesday there were 4741 companies with "abnormal" market making, 3722 companies with positive Friction Factors and 1380 companies with negative Friction Factors. Here is a list of the top companies with the largest percentage gain per share Tuesday and low price friction (bullish). This means that there was more buying than selling in the stocks and their stock prices rose faster with less Friction. Forest Oil Corp (NYSE:FST), Unisys Corp (NYSE:UIS), HealthStream Inc (NASDAQ:HSTM), MEI DIVERSIFIED LIQU (:MEIL), Vapor Corp (OTC:VPCO), (NASDAQ:MBII). To access Friction Factor, Naked Short Data and SqueezeTrigger Prices on all stocks please visit http://www.buyins.net .
MBII: 2.99 (-0.08), FST: 0.34 (-0.02), HSTM: 29.18 (+0.21), UIS: 29.77 (-0.43), VPCO: 1.30 (-0.01)
